Indeed, PD-1/PD-L1 blockade may potentially exert detrimental effects on the immune system via several mechanisms, including upregulation of regulatory T cells (Tregs), modulation of tumor-promoting cells, aberrant inflammation leading to angiogenesis and tissue remodeling, and activation of oncogenic pathways [24]. Here, PDCD1 is linked to neoplasm.